Clinical Manifestations, Fluid Changes and Neuroimaging Alterations in Patients with General Paresis of the Insane.
clinical manifestation
dementia
fluid changes
general paresis of the insane
neuroimaging alterations
Journal
Neuropsychiatric disease and treatment
ISSN: 1176-6328
Titre abrégé: Neuropsychiatr Dis Treat
Pays: New Zealand
ID NLM: 101240304
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
08
2020
accepted:
08
12
2020
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
21
1
2021
Statut:
epublish
Résumé
We aim to study the clinical manifestations, fluid changes and neuroimaging alterations in patients with general paresis of the insane (GPI). A total of 119 patients suffering from GPI recruited in Beijing Ditan Hospital, Capital Medical University from 2010 to 2020 were retrospectively analyzed. In 119 GPI patients, 103 cases (86.6%) were male. Misdiagnosed rate was up to 83.2%, schizophrenia and mood disorders were the most common misdiagnosed diseases. Duration from symptom onset to the final confirmed diagnosis was 10.4±12.9 months. The main clinical manifestations included cognitive impairment (114 cases, 95.8%) and neuropsychiatric symptoms (107 cases, 90.0%). The cognitive domains including the delayed recall, visuospatial/executive function and language ability indicated by MoCA score were damaged severely. Rapid plasma regain (RPR) of all GPI patients was 100% positive in serum and 89.9% positive in cerebral spinal fluid (CSF). The white blood cell (WBC) number in CSF was between 6 and 50/μL in 73 GPI patients (61.3%). The protein level was between 45.1 and 70mg/dL in 47 cases (39.5%). In the 110 cases, 96 cases (87.3%) were abnormal indicated by cerebral atrophy mostly located in the anterior brain and abnormal signals distributed in various regions of the brain mostly in the frontal lobe and temporal lobe. The symptoms of GPI were complex and easy to misdiagnose. The clinicians were still short of vigilance for neurosyphilis. We should expand serologic testing for syphilis especially in patients with cognitive impairment and neuropsychiatric symptoms. We suggest syphilis curricula in the training program of the clinicians especially for neurologist and psychiatrist.
Identifiants
pubmed: 33469294
doi: 10.2147/NDT.S279265
pii: 279265
pmc: PMC7812051
doi:
Types de publication
Journal Article
Langues
eng
Pagination
69-78Informations de copyright
© 2021 Gao et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1886-1900
pubmed: 27306850
Dement Geriatr Cogn Disord. 2017;43(5-6):308-319
pubmed: 28538242
Arch Neurol. 2005 Mar;62(3):447-53
pubmed: 15767510
Early Interv Psychiatry. 2019 Feb;13(1):30-38
pubmed: 28378939
Curr Pharm Des. 2012;18(4):466-78
pubmed: 22239577
World J Biol Psychiatry. 2009;10(2):127-55
pubmed: 19396704
N Engl J Med. 2019 Dec 12;381(24):2376-2377
pubmed: 31826357
Mov Disord. 2012 May;27(6):690-5
pubmed: 22410849
J Neuropathol Exp Neurol. 2018 Mar 12;:
pubmed: 29546365
J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):300-7
pubmed: 21948891
Intern Med. 2015;54(21):2769-73
pubmed: 26521909
Mov Disord. 2013 Feb;28(2):246-7
pubmed: 23166011
Psychopathology. 2014;47(1):3-9
pubmed: 23711816
Neuroradiology. 2013 Mar;55(4):379-88
pubmed: 23274762
Mov Disord. 2000 Jul;15(4):730-1
pubmed: 10928586
Sci Rep. 2017 Nov 13;7(1):15456
pubmed: 29133821
J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1581-93
pubmed: 25348878
Sex Transm Dis. 2018 Mar;45(3):147-151
pubmed: 29420441
Sci Rep. 2017 Mar 24;7:45339
pubmed: 28338084
Dement Geriatr Cogn Disord. 2011;31(4):284-90
pubmed: 21502759
Actas Dermosifiliogr. 2019 Dec;110(10):841-849
pubmed: 31587806
Eur Neurol. 2018;80(1-2):82-86
pubmed: 30343296
Dermatology. 2013;226(2):148-56
pubmed: 23615173
Cereb Cortex. 2013 Jul;23(7):1663-72
pubmed: 22669970
J Neuropsychiatry Clin Neurosci. 2008 Fall;20(4):490-3
pubmed: 19196937
BMC Infect Dis. 2018 Apr 2;18(1):144
pubmed: 29606102
S Afr Med J. 1992 Nov;82(5):335-7
pubmed: 1448714
CMAJ. 2018 Dec 17;190(50):E1482-E1483
pubmed: 31002652
Cochrane Database Syst Rev. 2016 Jan 13;(1):CD011145
pubmed: 26760674
J Infect Dis. 2004 Feb 1;189(3):369-76
pubmed: 14745693
Acta Neuropsychiatr. 2014 Jun;26(3):186-92
pubmed: 25142195
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
Neurol Res. 2014 Feb;36(2):137-42
pubmed: 24172279
N Engl J Med. 2016 Nov 17;375(20):e40
pubmed: 27959596
JAMA. 1972 Feb;219(6):726-9
pubmed: 5066697
J Neurol Sci. 2015 Mar 15;350(1-2):79-83
pubmed: 25703276
Eur Neurol. 2004;52(1):29-35
pubmed: 15237250
Biomed Res Int. 2019 May 6;2019:2426313
pubmed: 31198783
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Acta Radiol. 2006 Jul;47(6):609-11
pubmed: 16875341
BMC Psychiatry. 2016 Jul 11;16:230
pubmed: 27400713
BMC Geriatr. 2015 Sep 07;15:107
pubmed: 26346644
Biol Psychiatry. 1997 Feb 15;41(4):467-73
pubmed: 9034541
Eur Neurol. 2015;74(1-2):54-9
pubmed: 26183784